Use of carbenicillin and polymyxin B for therapy of gram-negative bacilli infections.
D000328:Adult; D000368:Aged; D001996:Bronchopneumonia / Q000188:drug therapy; D002228:Carbenicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use*; D011113:Polymyxins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy; D013997:Time Factors
D010406:Penicillins; D011113:Polymyxins; D002228:Carbenicillin